Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration.

Kato, Nobuhiro; Haruta, Masatoshi; Furushima, Kei; Arai, Rikki; Matsuo, Yu; Yoshida, Shigeo

Kato, Nobuhiro; Haruta, Masatoshi; Furushima, Kei; Arai, Rikki; Matsuo, Yu; Yoshida, Shigeo.

Afiliación

Kato N; Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan.
Haruta M; Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan.
Furushima K; Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan.
Arai R; Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan.
Matsuo Y; Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan.
Yoshida S; Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan.

Clin Ophthalmol ; 17: 1187-1192, 2023.

Article en En | MEDLINE | ID: mdl-37096209

Palabras clave

anti-vascular endothelial growth factor agents; choroid; laser speckle flowgraphy; mean blur rate; optic nerve head

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Ophthalmol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google